Symbicort contains the active medications budesonide and formoterol. Budesonide belongs to a drug class called corticosteroids. Formoterol belongs to a drug class called long-acting beta2 agonists.
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announced the U.S. Food and Drug Administration (FDA) has approved updates to the SYMBICORT ® (budesonide ...
AstraZeneca's Symbicort is racing toward patent expiration. But on Thursday, the company won six more months of exclusivity for the asthma and COPD inhaler. (Photo by Jonathan Ferrey/Getty Images) ...
The victory marks the fourth Symbicort patent deemed invalid or not infringed in court, Viatris and Kindeva pointed out. (Viatris) In the courtroom fracas over the patents on AstraZeneca’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results